• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Latvia·Consumer Cyclical·MDARA.RG
Share

AS MADARA Cosmetics Stocks

€ 12.3Last Updated 22.05.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 54.25M

€ 12.3
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

25.02.2026 16:33

Freedom24-Lithuania head shares Baltic small-cap stocks and sectors with 2026 upside

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

AS MADARA Cosmetics, together with its subsidiaries, produces and sells natural and organic cosmetics under the MADARA and MOSSA brand names in the Baltic and Nordic region. The company offers various face and body moisturisers, high-end makeup, advanced mineral sunscreens, perfumes, active ingredient concentrates, and other beauty products. It also provides contract manufacturing services for cosmetic products. The company exports its products to approximately 30 countries, primarily within the European Union. It offers its products through online stores. The company was incorporated in 2006 and is based in Marupe, Latvia.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA, reasonably priced o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.05.2026 15:15

A bid for a monopoly in space and a premium for faith: what SpaceX's IPO means for investors

26.05.2026 14:53

Starbucks in Korea has apologized for the scandalous ads. He expects a big drop in sales

26.05.2026 13:10

Ferrari has revealed an electric car with a controversial design from the iPhone's creator. What about the stock

26.05.2026 12:38

Iran war spurs $10 bln Kazakhstan project between China and EU

26.05.2026 11:01

Brent price drop reversed to a surge after new US strikes on Iran

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026